Heart Shrinkage Linked to Popular Weight-Loss Drug Ozempic/Semaglutide
14 Articles
14 Articles
“Abuse is expensive and deprives patients who really need it”: Ozempic at the heart of an explosion of non-compliant reimbursements
Between January 2021 and May 2024, more than 20 million euros were reimbursed for non-compliant prescriptions from Ozempic and Rybelsus. These drugs against type 2 diabetes, sometimes misused for their appetite-suppressing effects, cause worrying excesses....
Ozempic, the miracle to lose weight that is consumed in secret: "They tell me it is an option for bums"
"I've never been a thin person, I've always been overweight."This is how Jenny, a 39-year-old Lleida administrative who prefers not to give her last name, how her physical has been until, seven months ago, the Ozempic, the antidiabetic drug that is revolutionizing the fight against overweight across the planet, came into her life.Then she weighed 30 kilos more than now, despite having spent half a lifetime trying to lose weight through diets and…
Heart Shrinkage Linked to Popular Weight-Loss Drug Ozempic/Semaglutide
Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, potentially leading to serious health complications over time. Experts call for more research and a cautious approach to using these drugs, stressing the need for proper diet and exercise to mitigate risks. New Study Raises Concerns About Weight-Loss [...]
GLP-1 drugs like Ozempic may have health benefits, but they come with risks
Several years ago, a little-known drug named Ozempic—previously used only to treat diabetes—emerged as a promising new drug for weight management. The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class of drugs called glucagon-like peptide-1 agonists, or GLP-1. Today, GLP-1 drugs, including Wegovy, Mounjaro, and Zepbound, have become household names and key tools in the fight a…
Coverage Details
Bias Distribution
- 63% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage